Following years of devastating fatalities tied to fentanyl, health authorities are now sounding the alarm about an even more potent synthetic opioid entering communities.
Known as cychlorphine (pronounced sy-KLOR-feen), this lab-made substance belongs to a category of drugs called orphines. Initially synthesized in the 1960s by investigators searching for powerful analgesics, orphines were ultimately deemed excessively strong and hazardous, leading the U.S. Food and Drug Administration to withhold medical approval entirely.
Classified under federal law as a Schedule I substance, cychlorphine remains illegal to possess or distribute. Nonetheless, it has seen an uptick in overdose connections following China’s regulatory restrictions on synthetic opioids known as nitazenes.
Substance monitors in the U.S. first detected cychlorphine within the illicit market in 2024, around the same time discussions about it surfaced online via Reddit. Today, the compound is increasingly generating news reports due to fatal overdoses.
It was tied to the death of a 16-year-old in San Francisco this past April. Additionally, authorities in Knoxville, Tennessee, reported that cychlorphine was identified in roughly 50 suspected overdose fatalities between July 2025 and early June.
Similar safety bulletins warning residents of the dangers have been issued by public health departments in Louisiana and Los Angeles County.
How widespread is cychlorphine across the nation?
According to the White House Office of National Drug Control Policy, a single instance of cychlorphine was documented in the domestic drug supply in 2024. By 2025, that figure rose to 16 documented encounters spanning 10 states.
While orphines do not currently appear ubiquitous nationwide, tracking their exact trajectory remains difficult, noted Jason R. Williams, a researcher at the University of Washington’s Addictions, Drug & Alcohol Institute.
He explained that hospital toxicology screenings, medical examiner evaluations, and even forensic labs frequently fail to identify specific compounds until active surveillance and dedicated testing protocols are established.
Federal drug control officials note that the substance currently shows the highest concentration in Ohio, Texas, and Tennessee.
Following a fatal incident in Los Angeles County, local health officials cautioned that cychlorphine is being covertly blended into the unregulated drug supply. Investigators have discovered the substance disguised as counterfeit prescription pills, as well as in powder, crystalline, rock, and liquid forms, they added.
Just how powerful is cychlorphine?
While the Drug Enforcement Administration classifies fentanyl—a medically approved synthetic opioid—as roughly 100 times stronger than morphine, laboratory evaluations suggest cychlorphine dwarfs even that potency.
Alex Krotulski, director of toxicology and chemistry at the Center for Forensic Science Research and Education, noted that lab assays indicate cychlorphine is roughly 10 times more potent than fentanyl.
“That’s the only data that we have right now,” Krotulski stated. Because fentanyl has undergone human clinical research while cychlorphine has not been evaluated in human or animal subjects, he added, “We’re really finding out in real time what its effects on humans are.”
Nevertheless, a user’s physical reaction depends heavily on dosage size rather than sheer potency alone.
What are the indicators of a cychlorphine overdose?
The clinical signs of toxic exposure to cychlorphine closely mirror those seen with other opioids like fentanyl. Symptoms include severely constricted pupils, shallow or suppressed breathing, and an overall depression of the central nervous system that slows heart rate and other vital neural functions.
Los Angeles County health representatives emphasized that even an extremely minute quantity of cychlorphine is capable of causing respiratory arrest.
Does naloxone remain effective against cychlorphine overdoses?
Yes, the standard overdose-reversal medication naloxone can successfully counteract the drug.
However, much like severe fentanyl emergencies, the extreme potency of cychlorphine means reversing an overdose may necessitate multiple successive doses of naloxone.
Because over-the-counter or prescribed naloxone kits generally come packaged with two doses, individuals carrying the spray frequently possess only a limited supply. This highlights why contacting 911 immediately during a suspected overdose is critical, as emergency personnel can administer additional interventions if required.
Furthermore, identifying a cychlorphine overdose can be difficult. The substance escapes detection on standard hospital urine toxin panels and standard drug test strips, meaning exposures can easily go unnoticed.
What do tracking figures reveal about cychlorphine-related mortality?
While documentation of cychlorphine overdoses is rising, inconsistent testing practices across laboratories continue to obscure broader trends.
The White House Office of National Drug Control Policy cataloged 55 fatalities tied to cychlorphine throughout 2025 and leading up to April 2026.
According to Krotulski, testing facilities at the Center for Forensic Science Research and Education began spotting cychlorphine in late 2025, with identifications surging in 2026. Over a roughly seven-month window, his laboratory linked upwards of 140 deaths across the United States and Canada to the drug.
Williams noted that nearly all U.S. orphine-positive samples—and the vast majority of associated deaths—involve combinations of multiple substances.
This polysubstance use complicates cause-of-death determinations, as routine toxicology screens may not flag uncommon compounds unless investigators have specific reason to probe beyond standard parameters, he explained.
“It’s really unknown truly how many deaths there have been, but certainly in that short period of time, that is a significant number for a newly emerging drug like this,” Krotulski remarked.
If a deceased individual has a documented history of opioid dependence and scene evidence points toward an overdose, but routine screens fail to find fentanyl or traditional opioids, medical examiners may then specifically test for orphines like cychlorphine.
However, Williams pointed out that if initial panels successfully uncover fentanyl, the investigation may conclude there, leaving any underlying presence of cychlorphine entirely undetected.
RELATED: Ketamine: What to know about the sedative drug some college students are using recreationally